Mots-clés
> MYOBASE > BIOLOGIE > biologie par discipline > physiologie > métabolisme > catabolisme > métabolisme énergétique
métabolisme énergétiqueSynonyme(s)energetic metabolism energy metabolism |
Documents disponibles dans cette catégorie (549)
trié(s) par (Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
Etendre la recherche sur niveau(x) vers le bas
Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Rocher C ; Bénard G ; Pierron D ; Faustin B ; Malgat M ; Rossignol R ; Letellier T | 2005Communication n° 15. Mitochondria possess its own circular double strand DNA (mtDNA) that is present in multiple copies in mammalian cells. However, this number can vary according to the nature and to the steady state of studied tissues[1,2]. In[...]Article
Jongpiputvanich S ; Sueblinvong T ; Norapucsunton T | 2005Accès au résumé PubMed / to PubMed abstractArticle
Mancuso M ; Ferraris S ; Nishigaki Y ; Azan G ; Mauro A ; Sammarco P ; Krishna S ; Tay SKH ; Bonilla E ; Romansky SG ; Hirano M | 2005Accès au résumé PubMed / to PubMed abstract Une mutation de l'ADN mitochondrial entraîne une myopathie congénitale ou une myopathie à début tardif fréquemment associées à un diabète (22/03/05) Des mutations de l'ADN mitochondrial sont [...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Peltzer J ; Musa H ; Peckham M ; Keller A | 2005Communication n° 273. Introduction : The regulation of striated muscle plasticity and its involvement in coordination of energy metabolism and contractile phenotype remain obscure. Using an animal model for reduced contractile activity, we previ[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Rossignol R ; Faustin B ; Bénard G ; Rocher C ; Malgat M ; Mazat JP ; Dacharry-Prigent J ; Letellier T | 2005Communication n° 4. Mitochondrial diseases are caused by mutations in mitochondrial or nuclear DNA. They generally lead to the impairement of mitochondrial oxidative phosphorylation that is responsible for cellular energy deprivation and redox i[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Bénard G ; Faustin B ; Rocher C ; Malgat M ; Dacharry-Prigent J ; Rossignol R ; Letellier T | 2005Communication n° 11. To understand the physiopathology of mitochondrial diseases and explore potential metabolic therapeutic approaches necessitates a fundamental study of the biochemical mechanisms that intervene in the compensation for a pertu[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Nascimiento A ; Sans A ; Briones P ; Montoya J ; Andreu T ; Pineda M ; Colomer J | 2005Communication n° 54. Introduction : Decrease mitochondrial thymidine kinase (TK2) activity is associated with mitochondria DNA (mt DNA) depletion syndromes (MDS) and respiratory chain dysfuntion. Mutations in TK2 gene have been associated with i[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Letellier T ; Faustin B ; Rocher C ; Bénard G ; Malgat M ; Rossignol R | 2005Communication n° 7. The existence of a biochemical threshold effect in the metabolic expression of oxidative phosphorylation deficiencies has considerable implications for the understanding of mitochondrial bioenergetics and the study of mitocho[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Uzenot D ; Verschueren A ; Attarian S ; Vianey-Saban C ; Pellissier JF ; Pouget J | 2005Communication n° 679 INTRODUCTION ETF-QO deficiency is a rare cause of myopathy. Three forms have been described : two forms with a neonatal onset (type I,II), and a late onset form (III). Very few late onset cases have been published in adultho[...]Article
Ollivier K ; Hogrel JY ; Gomez-Merino D ; Romero NB ; Laforet P ; Eymard B ; Portero P | 2005Article
Chen YW ; Nagaraju K ; Bakay M ; McIntyre O ; Rawat R ; Shi R ; Hoffman EP | 2005Accès au résumé PubMed / to PubMed abstractArticle
Accès au résumé PubMed / to PubMed abstractLivre
Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Barani A ; Pradat P ; Frachon P ; Lombès A ; Meininger V ; Butler-Browne GS ; Mouly V | 2005Communication n° 300 Amyotrophic Lateral Sclerosis (ALS) is the most frequent fatal motoneuron disease. Degeneration of the motoneurons causes a progressive paralysis of the limbs, an amyotrophy and respiratory insufficiency, which is the main c[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Arbogast S ; Reid MB | 2005Communication n° 309 Under physiological conditions, muscle fibers continually produce reactive oxygen species (ROS) and nitric oxide (NO). Intracellular oxidant activity is increased by fatiguing exercise, inflammatory mediators, and heat stres[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Sirvent P ; Lacampagne A ; Vassort G ; Raynaud E ; Bordenave S ; Vermaelen M ; Mercier J | 2005Communication n° 570. Statin drugs represent the major improvement in the treatment of hypercholesterolemia. Beneficial effects of these drugs are numerous. Nevertheless, statins present side effects on muscle function characterized by myalgia, [...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Fergani A ; Dupuis L ; Gonzales De Aguilar J ; Oudart H ; Loeffler JP | 2005Communication n° 710 Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease characterized by selective loss of motor neurons and progressive muscle wasting. We have recently shown that mutant Cu/Zn-superoxide dismutase t[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Lamperti C ; Naini A ; Lucchini V ; Zecca C ; Ciscato P ; Serafini M ; Prelle A ; Bresolin N ; Moggio M | 2005Communication n° 368. Statins ( HMG CoA reductase) reduce colesterol by reducing the sythesis of mevalonate, a intermediary in the cholesterol pathway. This therapy can be associated with different degrees of skeletal muscle disorders varying fr[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Escobar R ; Montes de Oca B ; Miranda A ; Martinez G ; Rodriguez R ; Lona S ; Diaz A | 2005Communication n° 152 Background : Duchenne muscular dystrophy (DMD) it's an X-linked recessive neuromuscular disorder, it causes progressive muscular weakness and wheelchair dependency before 13 years of age. No definitive treatment exists and a[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Malka F ; Frachon P ; Lombès A ; Rojo M | 2005Communication n° 445. Mitochondria are essential organelles that produce the major part of intracellular ATP by oxidative phosphorylation and are involved in numerous metabolic pathways. They are dynamic organelles that form elongated and branch[...]Article
McFarland R ; Schaeffer AM ; Gardner JL ; Lynn S ; Hayes CM ; Barron MJ ; Walker MD ; Chinnery PF ; Taylor RW ; Turnbull DM | 04/2004Accès au résumé Pubmed/to pubmed abstractArticle
Article
Bykhovskaya Y ; Casas K ; Mengesha E ; Inbal A ; Fischel-Ghodsian N | 2004Accès au résumé PubMed / to PubMed abstract Une mutation faux-sens dans la pseudouridine synthase 1 (PUS1) est la cause la myopathie mitochondriale avec anémie sidéroblastique (26/07/2004) La myopathie mitochondriale avec anémie s[...]Article
Orngreen MC ; Norgaard MG ; Sacchetti M ; van Engelen BGM ; Vissing J | 2004Accès au résumé PubMed / to PubMed abstract